00
Shanghai RAAS
002252.SZ·SZSEShanghai CNFounded 20005,000 employees
Mid CapbiotechPublicHematology
Platform: Plasma Products
Market Cap
$4B
All Drugs
3
Clinical Trials
10
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (002252.SZ)
Loading 002252.SZ stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 002-5533 | 002-5533 | Phase 2/3 | 2 | AuroraA | NSCLC | ||
| Tixainavolisib | 002-4172 | Phase 3 | 4 | PLK4 | PVSchizophrenia | ||
| 002-1797 | 002-1797 | Approved | 4 | LAG-3 | Huntington's |
SEC Filings & Financial Documents
SEC filings are not available for SZSE-listed companies.
Shanghai RAAS trades on SZSE (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (11)